Peter Finan

Biography

Peter Finan has more than twenty years of experience in drug discovery within the pharmaceutical industry. Prior to joining Epidarex, Dr. Finan was Global Head of the Respiratory Disease Area and Site Head for the Novartis Institute of BioMedical Research in the United Kingdom. He is a former Executive Director of the Novartis Developmental and Molecular Pathways Platform based in Cambridge, Massachusetts. Earlier in his career, Dr. Finan worked at Cancer Research UK and the Yamanouchi Research Institute (now Astellas) and served as the Head of Biology at Karus Therapeutics. Dr. Finan currently serves on the Board of Directors of Caldan Therapeutics Ltd., Clyde Biosciences Ltd., Enterprise Therapeutics Ltd., Mironid Ltd., and Topas Therapeutics Ltd. Dr. Finan holds a BSc and Ph.D. in Biochemistry and Molecular Biology from the University of Leeds.

Research Interest

Biochemistry and Molecular Biology